CG
RMD icon

Clinton Group’s ResMed RMD Stock Holding History

Clinton Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,163
Closed -$474K – 485
2017
Q3 		$474K Buy
+6,163
New +$471K 0.05% 294
2016
Q4 		– Sell
-94,024
Closed -$6.09M – 969
2016
Q3 		$6.09M Buy
+94,024
New +$6.26M 0.29% 100
2016
Q1 		– Sell
-41,974
Closed -$2.25M – 982
2015
Q4 		$2.25M Buy
+41,974
New +$2.37M 0.18% 180
2015
Q3 		– Sell
-30,857
Closed -$1.74M – 815
2015
Q2 		$1.74M Buy
+30,857
New +$1.95M 0.24% 134
2014
Q4 		– Sell
-6,270
Closed -$309K – 554
2014
Q3 		$309K Buy
+6,270
New +$319K 0.13% 266
2014
Q2 		– Sell
-13,725
Closed -$613K – 410
2014
Q1 		$613K Buy
13,725
+5,449
+66% +$245K 0.23% 136
2013
Q4 		$390K Buy
+8,276
New +$419K 0.13% 195

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Clinton Group's RMD Position: Q4 2017 in Review

Clinton Group sold out of ResMed (RMD) in Q4 2017, closing a stake of 6,163 shares — an estimated $474K sold.

Clinton Group first reported a position in RMD in Q4 2013 and held it in 7 quarters. The position peaked at $6.09M in Q3 2016. 415 funds tracked by Wall St. Rank hold RMD as of Q4 2017.

  • Clinton Group reported no remaining ResMed position as of Q4 2017 after selling out during the quarter.
  • Clinton Group sold 6,163 ResMed shares in Q4 2017, an estimated $474K.
  • Clinton Group first reported a position in ResMed in Q4 2013 and held it in 7 quarters.
  • Clinton Group's ResMed position peaked at $6.09M in Q3 2016.
  • 415 funds tracked by Wall St. Rank held ResMed as of Q4 2017.

Based on Clinton Group's 13F filing for Q4 2017, filed 14 Feb 2018.